Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Perfusion Bioreactors Market Size, Share, and Trends Report, 2026-2033 | Revenue to Reach USD 839.8 Million as Biologics and Cell Therapies Drive 8.9% CAGR

globenewswire.com
DHR Cytiva, a subsidiary of Danaher Corporation, is mentioned as a key player in the perfusion bioreactors market, indicating its involvement in this growing sector. The article does not provide specific sentiment towards Danaher itself but highlights its subsidiary's role. TMO Thermo Fisher Scientific Inc. is listed as a company featured in the report on the perfusion bioreactors market. The article does not provide specific sentiment towards Thermo Fisher but indicates its presence in the industry.

Global Perfusion Bioreactors Market Size, Share, and Trends Report, 2026-2033 | Revenue to Reach USD 839.8 Million as Biologics and Cell Therapies Drive 8.9% CAGR Dublin, Nov. 10, 2026 (GLOBE NEWSWIRE) -- "Perfusion Bioreactors Market Size, Share & Trends Analysis Report by Type, Application, End Use, Region, and Segment Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

Global perfusion bioreactors market projected to reach USD 839.8 million by 2033

The global perfusion bioreactors market was valued at USD 430.5 million in 2025 and is anticipated to reach USD 839.8 million by 2033. The market is expected to expand at a compound annual growth rate of 8.9% from 2026 to 2033, supported by growing investment in advanced biopharmaceutical manufacturing and continuous bioprocessing technologies.

Demand for high-yield production systems is increasing as biopharmaceutical manufacturers seek to improve process efficiency, productivity, scalability, and product consistency. Perfusion bioreactors support continuous cell culture operations and are increasingly being incorporated into production workflows for monoclonal antibodies, vaccines, recombinant proteins, and other biologic products. The expanding pipeline of cell and gene therapies is also contributing to the adoption of these systems across research, development, and commercial manufacturing environments.

The report provides revenue forecasts at the global, regional, and country levels, along with an analysis of market trends across key sub-segments from 2021 to 2033. Market coverage is organized by type, application, end use, and region, offering insight into the principal areas shaping demand and investment.

Market segmentation by type

Small scale systems serve research, process development, and specialized production requirements, while large scale perfusion bioreactors address higher-volume biopharmaceutical manufacturing needs. Analysis by type evaluates revenue opportunities and evolving adoption patterns across the forecast period.

Market segmentation by application

Biopharmaceutical production represents a central application area, driven by increased manufacturing of antibodies, vaccines, and recombinant proteins. Tissue engineering and stem cell research further broaden the market opportunity as organizations advance regenerative medicine programs and cell-based research initiatives.

Market segmentation by end use

Biopharmaceutical companies are adopting perfusion bioreactor technologies to support production capacity and pipeline development. Academic and research institutes use these platforms for experimental and translational programs, while CROs & CMOs contribute to market growth by providing outsourced research, development, and manufacturing services.

Regional market coverage

The regional analysis examines revenue performance and current trends across major biopharmaceutical markets. North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa are assessed to identify geographic demand patterns and long-term growth opportunities. Country-level coverage provides additional insight into markets where biomanufacturing capacity, research activity, and therapeutic development may influence the adoption of perfusion bioreactors through 2033.

Key Attributes:

Key Topics Covered:

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope

1.2. Market Definitions

1.2.1. Type

1.2.2. Application

1.2.3. End User

1.3. Information Analysis

1.4. Market Formulation & Data Visualization

1.5. Data Validation & Publishing

1.6. Information Procurement

1.6.1. Primary Research

1.7. Market Model

1.8. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Ancillary Market Outlook

3.2. Market Trends and Outlook

3.3. Market Dynamics

3.3.1. Market Driver Impact Analysis

3.3.1.1. Increasing demand for continuous and high-yield bioprocessing

3.3.1.2. Rising production of biologics

3.3.1.3. Growth in the cell and gene therapy pipeline

3.3.2. Market Restraint Impact Analysis

3.3.2.1. Limited standardization of perfusion processes

3.3.2.2. Stringent regulatory validation and compliance requirements

3.3.3. Market Challenges Analysis

3.3.4. Market Opportunity Analysis

3.4. Case Study Insights

3.5. Business Environment Analysis

3.5.1. PESTLE Analysis

3.5.2. PORTER'S Five Forces Analysis

Chapter 4. Type Business Analysis

4.1. Type Segment Dashboard

4.2. Global Perfusion Bioreactors Market Type, Movement Analysis

4.3. Global Perfusion Bioreactors Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)

4.4. Small Scale Perfusion Bioreactors

4.4.1. Global small scale perfusion bioreactors market estimates and forecasts, 2021 - 2033 (USD Million)

4.5. Large Scale Perfusion Bioreactors

4.5.1. Global large scale perfusion bioreactors market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 5. Application Business Analysis

5.1. Application Segment Dashboard

5.2. Global Perfusion Bioreactors Market Application, Movement Analysis

5.3. Global Perfusion Bioreactors Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)

5.4. Biopharmaceutical Production

5.4.1. Global biopharmaceutical production market estimates and forecasts, 2021 - 2033 (USD million)

5.5. Tissue Engineering

5.5.1. Global tissue engineering market estimates and forecasts, 2021 - 2033 (USD million)

5.6. Stem Cell Research

5.6.1. Global stem cell research market estimates and forecasts, 2021 - 2033 (USD million)

5.7. Others

5.7.1. Global Others market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 6. End Use Business Analysis

6.1. End Use Segment Dashboard

6.2. Global Perfusion Bioreactors Market End Use, Movement Analysis

6.3. Global Perfusion Bioreactors Market Size & Trend Analysis, by End User, 2021 to 2033 (USD Million)

6.4. Biopharmaceutical Companies

6.4.1. Global biopharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD million)

6.5. Academic and Research Institutes

6.5.1. Global academic and research institutes market estimates and forecasts, 2021 - 2033 (USD million)

6.6. CROs & CMOs

6.6.1. Global CROs & CMOs market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 7. Perfusion Bioreactors Market: Regional Estimates and Trend Analysis, by Type, Application & End Use

7.1. Regional Dashboard

7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033

7.3. Country-level Analysis Framework

7.3.1. Key Country Dynamics

7.3.2. Competitive Scenario

7.3.3. Regulatory Framework

7.3.4. Country Market Estimates and Forecasts, 2021 - 2033 (USD Million)

7.4. North America

7.4.1. North America Perfusion Bioreactors Market, 2021 - 2033 (USD Million)

7.4.2. U.S.

7.4.3. Canada

7.4.4. Mexico

7.5. Europe

7.5.1. Europe Perfusion Bioreactors Market, 2021 - 2033 (USD Million)

7.5.2. UK

7.5.3. Germany

7.5.4. France

7.5.5. Italy

7.5.6. Spain

7.5.7. Denmark

7.5.8. Sweden

7.5.9. Norway

7.6. Asia Pacific

7.6.1. Asia Pacific Perfusion Bioreactors Market, 2021 - 2033 (USD Million)

7.6.2. Japan

7.6.3. China

7.6.4. India

7.6.5. Singapore

7.6.6. Australia

7.6.7. Thailand

7.6.8. South Korea

7.7. Latin America

7.7.1. Latin America Perfusion Bioreactors Market, 2021 - 2033 (USD Million)

7.7.2. Brazil

7.7.3. Argentina

7.8. MEA

7.8.1. MEA Perfusion Bioreactors Market, 2021 - 2033 (USD Million)

7.8.2. South Africa

7.8.3. Saudi Arabia

7.8.4. UAE

7.8.5. Kuwait

Chapter 8. Competitive Landscape

8.1. Company Categorization

8.2. Strategy Mapping

8.3. Company Market Position Analysis, 2025

8.4. Company Profiles/Listing

8.4.1. Company Profile Framework

8.4.1.1. Overview

8.4.1.2. Financial Performance

8.4.1.3. Product Benchmarking

8.4.1.4. Strategic Initiatives

8.4.2. Sartorius AG

8.4.3. Cell Culture Company

8.4.4. Cytiva (Danaher Corporation)

8.4.5. CELLEC BIOTEK AG

8.4.6. Synthecon Inc.

8.4.7. Getinge (Applikon Biotechnology B.V)

8.4.8. Zellwerk GmbH

8.4.9. Thermo Fisher Scientific Inc.

8.4.10. Eppendorf AG

8.4.11. Infors HT

8.4.12. 3D Biotek LLC

List of Tables [95]

List of Figures [85]

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/xqnj1w

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.